Millavelez, Cris .

HRN: 28-85-44  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/13/2026
CEFUROXIME 750MG (VIAL)
04/13/2026
04/19/2026
IV
750mg
Q12
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: